INE068V01023
INE068V01023
GLAND PHARMA LIMITED
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 505.23B EUR | 411.24B EUR | 279.44B EUR |
Enterprise Value | 473.7B EUR | 411.24B EUR | 248.69B EUR |
Valuation Multiples | |||
Trailing P/E | 44.72x | 35.43x | 27.13x |
Forward P/E | 31.78x | -- | -- |
Price to Sales | 7.51x | 6.1x | 4.39x |
Price to Book | 4.87x | -- | 2.7x |
EV/Revenue | 7.04x | 6.1x | 3.9x |
EV/EBITDA | 27.54x | 19.6x | 12.82x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -- | -- | -- |